Actively Recruiting
Feedback Intervention and Treatment Times in ST- Elevation Myocardial Infarction
Led by Karl Heinrich Scholz · Updated on 2023-03-30
50000
Participants Needed
1
Research Sites
1000 weeks
Total Duration
On this page
Sponsors
K
Karl Heinrich Scholz
Lead Sponsor
A
ALKK: Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausaerzte
Collaborating Sponsor
AI-Summary
What this Trial Is About
Part I (Pilot Phase): The purpose of this study is to examine if formalized data assessment and systematic feedback improves treatment times (i.e. contact-to-balloon time and door-to-balloon time) in patients with myocardial infarction with ST-segment elevation (STEMI). Part II (Implementation Phase): The Purpose is to prospectively investigate if survival can be improved by stringent use of this concept of formalized data analysis and systematic feedback of procedural and clinical data to all participating physicians and other members of the STEMI patients treating personnel. Part III (Advance Phase): The purpose is to develop, introduce and evaluate prospectively an automated, highly standardized feedback tool informing participating centers on key performance characteristics (procedural and clinical outcomes).
CONDITIONS
Official Title
Feedback Intervention and Treatment Times in ST- Elevation Myocardial Infarction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with STEMI and transported to the primary PCI center's cardiac catheterization laboratory for primary PCI
- STEMI defined by ST-segment elevation of 0.1 mV or more in at least two contiguous limb or precordial leads
- New or presumable new left bundle branch block with typical symptoms
You will not qualify if you...
- Patients with STEMI symptoms lasting longer than 24 hours are excluded from the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
St.Bernward Hospital
Hildesheim, Lower Saxony, Germany, 31134
Actively Recruiting
Research Team
K
Karl H. Scholz, MD.
CONTACT
T
Thomas Meyer, MD. PHD.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here